A simple and efficient multicomponent protocol, using ammonium deep eutectic solvent as a dual catalyst and environmentally benign reaction medium, is developed for the synthesis of dihydropyrano[2,3-c]pyrazole derivatives. This operationally simple protocol does not involve tedious workup or purification, affording the target compounds in short reaction times and excellent yields and avoiding the use of environmentally hazardous solvents and catalysts. GRAPHICAL ABSTRACT
An efficient, solid‐catalyst‐mediated Hantzsch synthesis of 1,4‐dihydropyridines is described. This procedure has such advantages as short reaction time, high yields, and simple workup. The catalyst could be reused several times and keeps its initial activity in the subsequent reactions.
An efficient one-pot, three-component synthesis of 3-pyrrolin-2-ones in aqueous media at room temperature is reported. This reaction provides a green and catalyst-free method for generation of 3-pyrrolin-2-one derivatives in good yields. GRAPHICAL ABSTRACT
Despite significant progress in cancer treatment, cancer remains a major focus of research due to medication resistance and side effects. In this study, bioactive adamantane-containing dihydropyrimidine (DHPM) derivatives were synthesized through the multi-component Biginelli reaction of N-(adamant-1-yl)acetoacetamide, benzaldehyde derivatives, and thiourea in the presence of trifluoroacetic acid (TFA, 2 mol%) as catalyst under solvent free conditions. This method provides an effective and significantly improved modification of the original Biginelli reaction in terms of yield and reaction time. The synthesized DHPM derivatives were subjected to cytotoxicity screening against the A-549 human non-small cell lung cancer (NSCLC) cell line to evaluate their effects on cell growth inhibition. MTT cytotoxicity assay was used to determine IC50 values. Among the target analogs, IIb, IIj, IId, and IIg demonstrated the best activity with IC50 values of 1.03, 8.36, 10.38, and 16.04 μg mL−1, respectively. Additionally, we assessed the possible mechanisms for cell growth inhibition and induction of apoptotic cell death using the DAPI and Annexin V-FITC staining. The average percentages of apoptotic cells were 21.35%, 28.35%, 32.73, and 43.33% for IIg, IId, IIj, and IIb treatment groups, respectively. These results suggest that the synthesized adamantane-containing dihydropyrimidines can be considered as encouraging molecules for further drug development as anticancer agents.